GATEWAY BIOTECHNOLOGY, INC.
Developing First-in-Class Drug Therapies for Hearing Disorders
SAINT LOUIS, United States · Founded 2016
- Headquarters
- SAINT LOUIS, Missouri
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2G
- Website
- gtwbio.com
About
Gateway Biotechnology is developing first-in-class small molecule and gene therapy-based treatments for hearing disorders including noise-induced hearing loss and tinnitus. Funded by NIH and the Department of Defense, the company has 7 SBIR/STTR grants, 2 patents, and 5 published papers, with its lead product undergoing a Phase II clinical trial under an exclusive U.S. Army contract.
Summary
GATEWAY BIOTECHNOLOGY, INC. is a Biotech company based in SAINT LOUIS, United States, founded in 2016.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gateway-biotechnology-inc"><img src="https://indexed.vc/api/badge/company/gateway-biotechnology-inc" alt="GATEWAY BIOTECHNOLOGY, INC. on Indexed.vc" width="260" height="76" /></a>